These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 7091432

  • 1. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC, Vroulis G, Shvartsburd A, Allen R, Lewis N, Schoolar JC, Chojnacki M, Johnson R.
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [Abstract] [Full Text] [Related]

  • 2. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J, Cooper TB, Meisner M, Bitter I, Czobor P, Jaeger J.
    Psychopharmacol Bull; 1990 Aug; 26(1):13-7. PubMed ID: 2371368
    [Abstract] [Full Text] [Related]

  • 3. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ, Janowsky DS, Perel JM, Munson E, Depry D.
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Haloperidol plasma levels and clinical response: a therapeutic window relationship.
    Van Putten T, Marder SR, Mintz J, Poland RE.
    Am J Psychiatry; 1992 Apr; 149(4):500-5. PubMed ID: 1554036
    [Abstract] [Full Text] [Related]

  • 6. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
    Magliozzi JR, Hollister LE, Arnold KV, Earle GM.
    Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
    [Abstract] [Full Text] [Related]

  • 7. Beyond the therapeutic window: a case presentation.
    Schulz SC, Butterfield L, Garicano M, Narasimhachari N, Friedel RO.
    J Clin Psychiatry; 1984 May; 45(5):223-5. PubMed ID: 6725212
    [Abstract] [Full Text] [Related]

  • 8. Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients.
    Hollister LE, Kim DY.
    Am J Psychiatry; 1982 Nov; 139(11):1466-8. PubMed ID: 7137396
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The relationship between plasma haloperidol concentrations and clinical results.
    Palao DJ, Araúxo A, Haro JM, Brunet M, Bernardo M.
    Arch Gen Psychiatry; 1996 Dec; 53(12):1167-9. PubMed ID: 8956684
    [No Abstract] [Full Text] [Related]

  • 15. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S, Rifkin A, Karajgi B, Cooper T, Borenstein M.
    J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
    [Abstract] [Full Text] [Related]

  • 16. Acutely psychotic patients receiving high-dose haloperidol therapy.
    Remington G, Pollock B, Voineskos G, Reed K, Coulter K.
    J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
    [Abstract] [Full Text] [Related]

  • 17. Haloperidol blood levels and clinical effects.
    Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou JC, Crowner M.
    Arch Gen Psychiatry; 1992 May; 49(5):354-61. PubMed ID: 1586270
    [Abstract] [Full Text] [Related]

  • 18. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
    Potkin SG, Shen YC, Zhou DF, Pardes H, Shu L, Phelps B, Poland R.
    Psychopharmacol Bull; 1985 May; 21(1):59-61. PubMed ID: 3983339
    [No Abstract] [Full Text] [Related]

  • 19. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A, Dekirmenjian H, Smith RC.
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [Abstract] [Full Text] [Related]

  • 20. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC, Baumgartner R, Misra CH, Mauldin M, Shvartsburd A, Ho BT, DeJohn C.
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.